Review



anti yap  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti yap
    Anti Yap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti yap/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    anti yap - by Bioz Stars, 2026-06
    86/100 stars

    Images



    Similar Products

    94
    MedChemExpress yap agonist
    <t>ITGB1/FAK/YAP</t> mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.
    Yap Agonist, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap agonist/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    yap agonist - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti yap
    <t>ITGB1/FAK/YAP</t> mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.
    Anti Yap, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti yap/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    anti yap - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress yap
    <t>ITGB1/FAK/YAP</t> mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.
    Yap, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    yap - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    86
    Sangon Biotech yap sirna
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Yap Sirna, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap sirna/product/Sangon Biotech
    Average 86 stars, based on 1 article reviews
    yap sirna - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Caire Inc yap taz
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Yap Taz, supplied by Caire Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap taz/product/Caire Inc
    Average 86 stars, based on 1 article reviews
    yap taz - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Novartis yap tead interaction inhibitor
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Yap Tead Interaction Inhibitor, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap tead interaction inhibitor/product/Novartis
    Average 86 stars, based on 1 article reviews
    yap tead interaction inhibitor - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Novartis yap tead allosteric inhibitor
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Yap Tead Allosteric Inhibitor, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap tead allosteric inhibitor/product/Novartis
    Average 86 stars, based on 1 article reviews
    yap tead allosteric inhibitor - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    96
    MedChemExpress yap inhibitor verteporfin
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Yap Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap inhibitor verteporfin/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    yap inhibitor verteporfin - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress cells
    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of <t>YAP</t> in mMGOs transfected with 3 types of <t>YAP-siRNA,</t> with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).
    Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cells/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cells - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    Image Search Results


    ITGB1/FAK/YAP mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.

    Journal: Bioactive Materials

    Article Title: From disease model to therapeutic insight: An engineered hydrogel reveals the role of matrix viscous dissipation in intervertebral disc degeneration

    doi: 10.1016/j.bioactmat.2026.02.021

    Figure Lengend Snippet: ITGB1/FAK/YAP mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.

    Article Snippet: During this period, in accordance with a previous study, 10 μL of FAK agonist (ZINC40099027, 10 μM, MCE, HY-134570) or YAP agonist (PY-60, 10 μM, MCE, HY-141644) were injected into the compressed IVDs every other day using a 31G needle.

    Techniques: Cell Culture, Immunofluorescence, Expressing, Western Blot

    Pharmacological activating of YAP alleviates NPCs senescence and IVDD progression. a, Schematic illustration of the in vivo experiments design. Rats received a FAK agonist or a YAP agonist every other day to indirectly or directly activate YAP. b, Images of rats IVDD model c, Representative MRI and X-ray images of the IVDs after injection of FAK agonist and YAP agonist with the corresponding quantitative analysis (n = 5). d, Representative H&E and S. O. staining of IVDs. Scale bars = 1 mm. e, Representative IF images of ACAN and COL II. Scale bars = 100 μm. f, Representative IF images of p16INK4a and YAP. g, Representative IHC images of cGAS with the corresponding quantitative analysis. Scale bars = 100 μm (n = 5). All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference compared to the control group, and the symbol “#” represents a statistical difference compared to the compression group.

    Journal: Bioactive Materials

    Article Title: From disease model to therapeutic insight: An engineered hydrogel reveals the role of matrix viscous dissipation in intervertebral disc degeneration

    doi: 10.1016/j.bioactmat.2026.02.021

    Figure Lengend Snippet: Pharmacological activating of YAP alleviates NPCs senescence and IVDD progression. a, Schematic illustration of the in vivo experiments design. Rats received a FAK agonist or a YAP agonist every other day to indirectly or directly activate YAP. b, Images of rats IVDD model c, Representative MRI and X-ray images of the IVDs after injection of FAK agonist and YAP agonist with the corresponding quantitative analysis (n = 5). d, Representative H&E and S. O. staining of IVDs. Scale bars = 1 mm. e, Representative IF images of ACAN and COL II. Scale bars = 100 μm. f, Representative IF images of p16INK4a and YAP. g, Representative IHC images of cGAS with the corresponding quantitative analysis. Scale bars = 100 μm (n = 5). All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference compared to the control group, and the symbol “#” represents a statistical difference compared to the compression group.

    Article Snippet: During this period, in accordance with a previous study, 10 μL of FAK agonist (ZINC40099027, 10 μM, MCE, HY-134570) or YAP agonist (PY-60, 10 μM, MCE, HY-141644) were injected into the compressed IVDs every other day using a 31G needle.

    Techniques: In Vivo, Injection, Staining, Control

    Viscous dissipation biomimetic hydrogel alleviates ECM remodeling and NPCs senescence during IVDD. a, Schematic diagram of the mechanical testing procedures. Axial tension-compression and stress-relaxation tests were conducted to evaluate the mechanical properties of IVDs at 12 weeks b, Representative force-displacement curves of all groups. c, Representative stress-relaxation curves of all groups. d, Quantitative analysis of compressive stiffness, tensile stiffness (n = 5). e, Quantitative analysis of normalized NZ and τ 1/2 (n = 5). h, Representative IF images of p16INK4a and YAP at 12 weeks. Scale bars = 50 μm and 20 μm, respectively. i, Representative IHC images of cGAS in NP tissues at 12 weeks. Scale bars = 100 μm (n = 5). The symbol “∗” represents a statistical difference compared to the sham group, and the symbol “#” represents a statistical difference compared to the defect group.

    Journal: Bioactive Materials

    Article Title: From disease model to therapeutic insight: An engineered hydrogel reveals the role of matrix viscous dissipation in intervertebral disc degeneration

    doi: 10.1016/j.bioactmat.2026.02.021

    Figure Lengend Snippet: Viscous dissipation biomimetic hydrogel alleviates ECM remodeling and NPCs senescence during IVDD. a, Schematic diagram of the mechanical testing procedures. Axial tension-compression and stress-relaxation tests were conducted to evaluate the mechanical properties of IVDs at 12 weeks b, Representative force-displacement curves of all groups. c, Representative stress-relaxation curves of all groups. d, Quantitative analysis of compressive stiffness, tensile stiffness (n = 5). e, Quantitative analysis of normalized NZ and τ 1/2 (n = 5). h, Representative IF images of p16INK4a and YAP at 12 weeks. Scale bars = 50 μm and 20 μm, respectively. i, Representative IHC images of cGAS in NP tissues at 12 weeks. Scale bars = 100 μm (n = 5). The symbol “∗” represents a statistical difference compared to the sham group, and the symbol “#” represents a statistical difference compared to the defect group.

    Article Snippet: During this period, in accordance with a previous study, 10 μL of FAK agonist (ZINC40099027, 10 μM, MCE, HY-134570) or YAP agonist (PY-60, 10 μM, MCE, HY-141644) were injected into the compressed IVDs every other day using a 31G needle.

    Techniques:

    ITGB1/FAK/YAP mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.

    Journal: Bioactive Materials

    Article Title: From disease model to therapeutic insight: An engineered hydrogel reveals the role of matrix viscous dissipation in intervertebral disc degeneration

    doi: 10.1016/j.bioactmat.2026.02.021

    Figure Lengend Snippet: ITGB1/FAK/YAP mechanotransduction axis mediates the regulation of ECM viscous dissipation on YAP. a, GSEA revealed that “Reactome integrin signaling”, “Gobo focal adhesion assembly”, “Gobo regulation of cytoskeleton” and “Kegg regulation of actin cytoskeleton” were upregulated in the NPCs cultured on V-gel compared with the NPCs cultured on E-gel. b, Heatmap of the series of DEGs related to mechanotransduction. c, Representative IF images of ITGB1 and YAP in NPCs with corresponding quantitative analysis, Scale bars = 50 μm d, Representative immunofluorescence images of p-FAK, Vinculin, YAP, and F-actin with quantitative analysis of cell areas, p-FAK expression and the ratio of nuclear YAP. Relative cell areas and nuclear YAP ratios were quantified across 50 cells from three independent biological replicates (n = 50). Relative fluorescent intensity of p-FAK was quantified from three independent biological replicates (n = 3). e, Western blotting analysis of YAP and p-YAP. All data are presented as means ± SD. Statistical significance was determined by one-way ANOVA with Tukey's multiple-comparisons test. p < 0.05 was considered statistically significant. The symbol “∗” represents a statistical difference.

    Article Snippet: Agonists in cell culture were used at the following concertation: 1.5 μM PY-60 to activate YAP (MCE, China, HY-141644), 0.8 μM Pyrintegrin to activate ITGB1 (MCE, China, HY-13306) and 10 nM ZINC40099027 to activate FAK (MCE, China, HY-134570).

    Techniques: Cell Culture, Immunofluorescence, Expressing, Western Blot

    (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of YAP in mMGOs transfected with 3 types of YAP-siRNA, with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).

    Journal: bioRxiv

    Article Title: Modeling Meibomian Gland Development and Dysfunction: A Mouse-Derived Organoid System Reveals Hippo-YAP as a Critical Regulator

    doi: 10.64898/2026.05.13.724874

    Figure Lengend Snippet: (A and B) Bright-field images of mMGOs treated with verteporfin, with DMSO as control. The axial length and the surface area of mMGOs were measured using ImageJ (n=35). (C and D) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (E and F) Percentage of Ki67 and EdU positive cells in (C and D) (n=8). (G) Relative mRNA expression of Ki67 (n=4) and Pcna (n=3) in mMGOs. (H and I) Western blot analysis of YAP in mMGOs transfected with 3 types of YAP-siRNA, with NC-siRNA as control, the protein levels were quantified by densitometry (n=3). (J and K) Bright-field images of mMGOs transfected with YAP-siRNA 3, with NC-siRNA as control. And the axial length and the surface area of mMGOs were quantified (n=24). (L and M) Immunofluorescence of Ki67 and EdU staining in mMGOs, nuclei were counterstained with DAPI. (N and O) Percentage of Ki67 and EdU positive cells in (L and M) (n=4). Scale bars represent 100 µm in (A) and (J), 50 µm in (C), (D), (L) and (M).

    Article Snippet: YAP expression was knocked down in mMGOs transfection with the YAP siRNA (Sangon Biotech) using RNATransMate (Sangon Biotech, E607402) following the manufacturer’s instruction, with negative control (NC) siRNA as control.

    Techniques: Control, Immunofluorescence, Staining, Expressing, Western Blot, Transfection

    (A and B) Immunofluorescence of YAP in MG of 8-week-old and 24-month-old mice, nuclei were counterstained with DAPI. And the ratio of nuclear YAP to cytoplasm YAP, three cells were randomly selected for measurement and averaged in each sample (n=5). (C and D) Bright-field images of mMGOs treated with LPS, with PBS as control. Number of budding (n=62) and the surface area (n=57) of mMGOs were quantified. (E) Immunofluorescence of Ki67 in mMGOs, nuclei were counterstained with DAPI. (F) TUNEL staining of mMGOs, nuclei were counterstained with DAPI. (G) Immunofluorescence of K10 in mMGOs, nuclei were counterstained with DAPI. (H) Percentage of Ki67 positive cells in (C) (n=6). (I) The percentage of TUNEL positive cells in (D) (n=5). (J) The intensities of K10 in (E) (n=3). (K and L) Immunofluorescence of YAP in LPS-induced MGD model in vitro , nuclei were counterstained with DAPI. And the ratio of nuclear YAP to cytoplasm YAP (n=4). (M and N) Bright-field images of mMGOs transfected with YAP-siRNA 3 after maturation, with NC-siRNA as control. Changes of budding number were quantified (n=3). (O and P) Bright-field images of mMGOs cultured with XMU-MP-1 after maturation, with DMSO as control. Number of budding (n=33) and the surface area (n=39) of mMGOs were quantified. Scale bars represent 250 µm in (C), 100 µm in (M) and (O), 50 µm in (E), (F) and (G), 25 µm in (A) and (K).

    Journal: bioRxiv

    Article Title: Modeling Meibomian Gland Development and Dysfunction: A Mouse-Derived Organoid System Reveals Hippo-YAP as a Critical Regulator

    doi: 10.64898/2026.05.13.724874

    Figure Lengend Snippet: (A and B) Immunofluorescence of YAP in MG of 8-week-old and 24-month-old mice, nuclei were counterstained with DAPI. And the ratio of nuclear YAP to cytoplasm YAP, three cells were randomly selected for measurement and averaged in each sample (n=5). (C and D) Bright-field images of mMGOs treated with LPS, with PBS as control. Number of budding (n=62) and the surface area (n=57) of mMGOs were quantified. (E) Immunofluorescence of Ki67 in mMGOs, nuclei were counterstained with DAPI. (F) TUNEL staining of mMGOs, nuclei were counterstained with DAPI. (G) Immunofluorescence of K10 in mMGOs, nuclei were counterstained with DAPI. (H) Percentage of Ki67 positive cells in (C) (n=6). (I) The percentage of TUNEL positive cells in (D) (n=5). (J) The intensities of K10 in (E) (n=3). (K and L) Immunofluorescence of YAP in LPS-induced MGD model in vitro , nuclei were counterstained with DAPI. And the ratio of nuclear YAP to cytoplasm YAP (n=4). (M and N) Bright-field images of mMGOs transfected with YAP-siRNA 3 after maturation, with NC-siRNA as control. Changes of budding number were quantified (n=3). (O and P) Bright-field images of mMGOs cultured with XMU-MP-1 after maturation, with DMSO as control. Number of budding (n=33) and the surface area (n=39) of mMGOs were quantified. Scale bars represent 250 µm in (C), 100 µm in (M) and (O), 50 µm in (E), (F) and (G), 25 µm in (A) and (K).

    Article Snippet: YAP expression was knocked down in mMGOs transfection with the YAP siRNA (Sangon Biotech) using RNATransMate (Sangon Biotech, E607402) following the manufacturer’s instruction, with negative control (NC) siRNA as control.

    Techniques: Immunofluorescence, Control, TUNEL Assay, Staining, In Vitro, Transfection, Cell Culture